Wealth Enhancement Advisory Services LLC Purchases 5,095 Shares of STERIS plc $STE

Wealth Enhancement Advisory Services LLC boosted its holdings in shares of STERIS plc (NYSE:STE) by 23.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 26,763 shares of the medical equipment provider’s stock after purchasing an additional 5,095 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in STERIS were worth $6,971,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. grew its position in STERIS by 0.4% in the third quarter. Vanguard Group Inc. now owns 12,213,521 shares of the medical equipment provider’s stock valued at $3,022,114,000 after acquiring an additional 50,393 shares during the last quarter. State Street Corp boosted its stake in shares of STERIS by 4.0% in the 3rd quarter. State Street Corp now owns 4,354,839 shares of the medical equipment provider’s stock valued at $1,077,564,000 after purchasing an additional 166,736 shares in the last quarter. Orbis Allan Gray Ltd grew its holdings in shares of STERIS by 36.0% during the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock valued at $504,486,000 after purchasing an additional 556,088 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of STERIS by 16.4% during the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,567,238 shares of the medical equipment provider’s stock valued at $387,797,000 after purchasing an additional 221,199 shares during the last quarter. Finally, Invesco Ltd. increased its position in STERIS by 4.9% during the 3rd quarter. Invesco Ltd. now owns 1,280,142 shares of the medical equipment provider’s stock worth $316,758,000 after purchasing an additional 59,443 shares in the last quarter. Institutional investors own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Six equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $275.20.

Insider Buying and Selling at STERIS

In related news, Director Cynthia L. Feldmann sold 3,098 shares of the business’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the sale, the director owned 705 shares of the company’s stock, valued at $167,233.05. The trade was a 81.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.07% of the stock is currently owned by corporate insiders.

STERIS Stock Performance

STERIS stock opened at $219.90 on Friday. The business has a 50 day moving average of $242.75 and a 200-day moving average of $248.76. STERIS plc has a 1 year low of $204.90 and a 1 year high of $269.44. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.48 and a quick ratio of 1.75. The company has a market capitalization of $21.57 billion, a P/E ratio of 30.67 and a beta of 1.05.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 EPS for the quarter, hitting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. During the same quarter in the prior year, the firm posted $2.32 EPS. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. On average, equities research analysts predict that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th were issued a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Tuesday, February 17th. STERIS’s payout ratio is 35.15%.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.